[Pharmacokinetics--pharmacodynamics of modafinil in mice]

Zhang-Qing Ma1, Zong-Yuan Hong, Wu-San Wang

  • 1Institute of Quantitative Pharmacology, Department of Pharmacology, Wannan Medical College, Wuhu 241002, China.

Insights

This study investigated modafinil (MOD) pharmacokinetics and pharmacodynamics in mice. Modafinil significantly increased locomotor activity, showing a strong correlation with its plasma concentration.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Drug Metabolism

Background:

  • Modafinil (MOD) is a wakefulness-promoting agent.
  • Understanding its pharmacokinetic and pharmacodynamic profile is crucial for clinical application.
  • Previous studies have explored its effects, but detailed correlation analysis in mice is needed.

Purpose of the Study:

  • To investigate the pharmacokinetics and pharmacodynamics of modafinil in mice.
  • To determine the correlation between modafinil plasma concentration and its locomotor activity effects.
  • To guide the rational clinical use of modafinil.

Main Methods:

  • Male Kunming mice received a single oral dose of modafinil (120 mg/kg).
  • Plasma modafinil concentrations were measured using High-Performance Liquid Chromatography (HPLC).
  • Locomotor activity was recorded using an infrared ray passive sensor.

Main Results:

  • Modafinil exhibited a two-compartment open model with first-order absorption.
  • Key pharmacokinetic parameters included t1/2α (0.42 h), t1/2β (3.10 h), tmax (1.00 h), Cmax (41.34 mg/L), and AUC(0-∞) (142.22 mg·h/L).
  • Modafinil significantly enhanced locomotor activity for approximately 4 hours, with synchronous changes in plasma concentration.

Conclusions:

  • A significant correlation exists between modafinil's effects and its plasma concentration in mice at the studied dose.
  • These findings support the rational clinical application of modafinil based on its concentration-effect relationship.
  • The study provides valuable data for understanding modafinil's action in a preclinical model.

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect01:28

Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect

A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship01:23

Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship

Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates that even as drug...